Halioua argues dogs beat mice as models because they are genetically diverse, share our environment and develop age-related diseases naturally. No peptide link is stated.
Recap by typeshit. Post by Celine Halioua on X.
Half of people with diabetes for 10 years or more said they were very satisfied on a GLP-1. Gen Z users were the most likely to stop and restart treatment.
64% of current users faced some negative reaction. Men, BIPOC respondents and the newly diagnosed reported it most, while 69% of boomers felt none.
The workflow uses glutathione or sulfatase triggers to target organelles and tumors in mice, and the authors say it takes 92 to 115 days to run.
A University of Pennsylvania mouse study found on-off GLP-1 use left mice 20 per cent heavier than those kept on the drug, and doctors warn human effects are unknown.
A press release announces Woodward's new book, which she says debunks common peptide myths aimed at women. No other details were given.
ASU's Justin Bina told the New York Post that people starting GLP-1 drugs become willing to pay more per pound for certain proteins, even as cattle stocks hit a 75-year low.
Loading…